Infant Phototherapy Device Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

Infant Phototherapy Market Outlooks

Infant phototherapy is a treatment for neonatal jaundice, which is a common condition of newborn babies caused by excessive amount of bilirubin in the blood. Bilirubin is a yellow pigment produced during the processes of red blood cell breakdown. When the liver of a neonate is unable to remove bilirubin it can accumulate and lead to jaundice.

Phototherapy is an exposure of a specific wavelength of light to the baby's skin, usually blue or green, which converts bilirubin into a water-soluble form, which can be excreted in urine or stool, thus lowering the bilirubin levels and preventing complications like brain damage or kernicterus. The developments in phototherapy devices, especially LED-based systems, have enhanced the efficiency and safety of treatment.

Growth Drivers in the Infant Phototherapy Market

Rising Prevalence of Neonatal Jaundice

The increasing prevalence of neonatal jaundice globally is a major driver for the infant phototherapy market. Neonatal jaundice affects a significant percentage of newborns due to high bilirubin levels, requiring effective treatments to prevent complications like brain damage. With improved diagnosis and awareness among healthcare providers and parents, the demand for phototherapy devices continues to rise. This trend is especially evident in regions with higher birth rates and underdeveloped healthcare systems, where neonatal jaundice remains a leading cause of hospitalization for newborns. In response to concerns over the growth of population, China relaxed its strict "one-child policy" in 2016 and then permitted couples to have as many as three children in 2021. According to NBS (National Bureau of Statistics, with 9.02 million births in 2023, there were 6.39 births per 1,000 people in China.

Phototherapy Technology Advancement

Technological advancement, which includes the design of LED-based phototherapy machines, has improved neonatal care. These devices are more energy efficient, have longer lifetimes, and target wavelengths more precisely, making them more effective in lowering bilirubin levels. In addition, portable and compact designs have made it easier to access remote or low-resource settings, ensuring timely treatment for newborns. Continuous innovation is expected to further drive market growth. November 2024 - NeoLight, the neonatal phototherapy innovator, has received a group purchasing agreement for its Skylife Neonatal Phototherapy System through Breakthrough Technology of Premier, Inc. This agreement will allow Premier members to purchase the Skylife system at significantly lower prices.

Increased Investment in Neonatal Care

Increased investment in neonatal healthcare infrastructure across developing nations is also driving the purchase of phototherapy devices. Governments and health institutions are working to decrease infant mortality by equipping hospitals and clinics with better and quality treatment options. Public and private initiatives are also underway for enhanced maternal and child health, and making phototherapy equipment more widespread, especially in remote areas. February 2024, The Paediatric Neuroimaging Group released a series of animations at the Department of Paediatrics to help parents better understand how premature infants' developing brains affect respiration and apneas, or the stopping of breathing.

Challenges in the Infant Phototherapy Market

High Cost of Phototherapy Devices

The biggest drawback for low-income nations remains the prohibitive initial investment in phototherapy devices. Advanced technology, such as LED phototherapy systems, is expensive and not accessible to many healthcare facilities. Maintenance and operational costs further add to the financial burden, limiting widespread adoption among regions with constrained healthcare budgets.

Access is scarce in rural areas

The majority of rural and remote areas are poorly equipped to deliver quality neonatal care, such as phototherapy. Ineffective treatment of neonatal jaundice results from poor facilities, unavailability of skilled practitioners, and difficulties in logistics. Improving health infrastructure and making resources more available and equitable are focused efforts that are needed to bridge this gap.

Fluorescent Lamps Infant Phototherapy Market

Fluorescent lamps have been traditional phototherapy tools because they have the capability of emitting light within the blue spectrum, which effectively breaks down bilirubin. However, the lamps are inferior in several respects, including short lifespan and greater energy consumption as compared to new technologies. In spite of that, they remain widely used due to their lower cost, and affordability is still a prime priority in most of the cost-sensitive markets.

Quartz Halogen Lamps Infant Phototherapy Market

Another available option in infant phototherapy is quartz halogen lamps, which emit very bright lights. They are more effective in short courses of treatment but produce a higher amount of heat and thus seem to increase the risk of thermal injury to newborns. Because of the improved availability of LED technology, there is a steady replacement of quartz halogen lamps with safer and efficient forms.

Mobile Device Infant Phototherapy Market

Mobile phototherapy devices are being picked up because they can be taken along easily. Easy to carry, they enable treatment in home care settings or remote locations. These tiny gadgets would be specifically useful in a rural or deprived area where healthcare centers are not easily accessible. It is easy to use and efficient, both for the parent and the healthcare provider.

Neonatal Clinics Infant Phototherapy Market

Neonatal clinics are an important part of the infant phototherapy market, as they provide specialized care to newborns suffering from jaundice. These clinics are equipped with advanced phototherapy devices and staffed by trained professionals, ensuring effective treatment. The growing number of neonatal clinics, especially in urban areas, has significantly improved access to quality care, contributing to market expansion.

United States Infant Phototherapy Market

The United States holds the highest position in the infant phototherapy market, mainly because of a well-established healthcare system, high awareness of neonatal jaundice, and significant spending on healthcare. The presence of key industry players and ongoing research initiatives further strengthens the market. Increasing demand for advanced phototherapy devices and growing adoption of home-based treatments are key trends in the U.S. market. November 2024 NeoLight's Skylife Neonatal Phototherapy System receives Breakthrough Technology group purchasing agreement from Premier, Inc. Under the agreement, Premier members will receive special pricing and terms on NeoLight's disruptive technologies.

France Infant Phototherapy Market

Infant phototherapy in France flourishes in a mature health care structure that offers diversified programs for neonatal care focusing on the safety and well-being of newborn babies. The government's interest in improving the health of mothers and children can be seen through various public awareness programs that encourage people to seek appropriate and timely treatments for diseases such as jaundice. This collective approach ensures that phototherapy treatments are available throughout the country. At the same time, the neonatal care scenario is becoming increasingly advanced with more investments in the latest technologies aimed at improving infant outcomes. This shall be fueling further growth in the market and positioning France as a frontrunner for innovative care towards a new-born baby.

India Infant Phototherapy Market

The Indian infant phototherapy market is growing extremely rapidly owing to the high birth rate in the country along with increasing awareness about neonatal jaundice. Urban regions enjoy superior healthcare facilities. Contrarily, its counterpart found in rural areas does not readily have the benefits of phototherapy devices. The initiative to enhance the rural healthcare infrastructure and provide cheaper solutions is anticipated to increase penetration in the market in the future. January 2024: Amrita Hospital, Faridabad, has announced India's first Mother-Neonatal Intensive Care Unit (M-NICU) that will enforce a "zero separation from birth" policy, thus strengthening the bond between mother and newborns. This initiative has been aligned with WHO research for immediate Kangaroo Mother Care in neonatal health.

Saudi Arabia Infant Phototherapy Market

The infant phototherapy market in Saudi Arabia is growing at a rapid pace, mainly due to the improvement of healthcare services and an increase in investments made in medical infrastructure. The government is actively working to improve neonatal care, which has led to a greater emphasis on addressing conditions such as jaundice in newborns. This heightened awareness among healthcare professionals and parents about the critical importance of early intervention further fuels the demand for phototherapy devices. In addition, the adoption of cutting-edge technologies in these treatments is expected to fuel the growth of the market and open up further avenues for more innovative solutions in neonatal care across the region.

Infant Phototherapy Device Market Segments

Light Source – Market breakup in 3 viewpoints:

1.    Fluorescent Lamps
2.    Light Emitting Diodes
3.    Quartz Halogen Lamps
4.    Gas Discharge Tubes

Configuration – Market breakup in 2 viewpoints:

1.    Mobile Device
2.    Fixed Device

End User – Market breakup in 2 viewpoints:

1.    Hospitals
2.    Neonatal Clinics

Country – Market breakup of 25 Countries:

1.    North America

1.1    United States
1.2    Canada

2.    Europe

2.1    France
2.2    Germany
2.3    Italy
2.4    Spain
2.5    United Kingdom
2.6    Belgium
2.7    Netherland
2.8    Turkey

3.    Asia Pacific

3.1    China
3.2    Japan
3.3    India
3.4    South Korea
3.5    Thailand
3.6    Malaysia
3.7    Indonesia
3.8    Australia
3.9    New Zealand

4.    Latin America

4.1    Brazil
4.2    Mexico
4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    South Africa

All the key players have been covered from 4 Viewpoints:

•    Overview
•    Product Portfolio
•    Recent Development
•    Revenue Analysis

Key Players Analysis:

1.    Ningbo David Medical Device Co.
2.    Ltd, Koninklijke Philips N.V.
3.    General Electric Company
4.    Inapiration Healthcare Group Plc
5.    Drägerwerk AG & Co. KGaA
6.    Ibis Medical Equipment and Systems Pvt Ltd.
7.    Weyer GmbH
8.    Natus Medical Incorporated.

Report Details: